DeDora Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Other funds holding CRSP
DeDora Capital's CRSP Position: Q3 2026 in Review
DeDora Capital opened a new position in CRISPR Therapeutics (CRSP) in Q3 2026: 38 shares worth $2.1K. The stake represents ﹤0.01% of the portfolio and ranks #398 among its holdings.
503 funds tracked by Wall St. Rank hold CRSP as of Q3 2026.
- DeDora Capital held 38 shares of CRISPR Therapeutics worth $2.1K as of Q3 2026.
- CRISPR Therapeutics was a new DeDora Capital position in Q3 2026.
- CRISPR Therapeutics made up ﹤0.01% of DeDora Capital's portfolio in Q3 2026, its #398 holding.
- 503 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2026.
Based on DeDora Capital's 13F filing for Q3 2026, filed 26 Oct 2026.